Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Development of Blood Vessels01:07

Development of Blood Vessels

2.0K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
2.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

7.8K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K
Hematopoiesis01:21

Hematopoiesis

10.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.1K
Skin Cancer01:30

Skin Cancer

6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

4.2K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemangiomas: Beyond the Skin.

Pediatrics in review·2026
Same author

A Case of Encephalocraniocutaneous Lipomatosis (ECCL) With Atypical Clinical Presentation Diagnosed on Molecular Testing: FGFR1 ECCL Tumor Risk.

American journal of medical genetics. Part A·2026
Same author

Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes.

Blood vessels, thrombosis & hemostasis·2026
Same author

Supporting evidence and recommendations for the management of patients with systemic-eligible atopic dermatitis: A Canadian consensus document.

JAAD international·2025
Same author

Incontinence-associated dermatitis: Not just babies.

Journal of the American Academy of Dermatology·2025
Same author

Paradigm shift in the management of infantile hemangiomas in the beta-blocker era: A retrospective cohort study.

Journal of the American Academy of Dermatology·2025
Same journal

Pigmented Basal Cell Carcinoma in Skin of Color: A Systematic Review of the Literature.

Journal of drugs in dermatology : JDD·2026
Same journal

Latin America Cutaneous Oncology Management (LACOM) II: A Practical Algorithm for Managing Skin Toxicities in Oncology Patients.

Journal of drugs in dermatology : JDD·2026
Same journal

Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation.

Journal of drugs in dermatology : JDD·2026
Same journal

Decoding Sensitive Skin Syndrome: International Expert Advisory Insights on Management From India and the United States of America.

Journal of drugs in dermatology : JDD·2026
Same journal

Evaluating the Safety and Efficacy of Sirolimus Topical Gel 0.2% to Treat Acanthosis Nigricans.

Journal of drugs in dermatology : JDD·2026
Same journal

Moringa-Derived Formulations for Hair Growth, Hair Preservation, and Hair Loss: A Systematic Review.

Journal of drugs in dermatology : JDD·2026
See all related articles

Related Experiment Video

Updated: Apr 13, 2026

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
05:30

Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

Published on: August 8, 2025

758

Infantile hemangiomas

Ilona J Frieden, Shanna Spring

    Journal of Drugs in Dermatology : JDD
    |May 6, 2015
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    A Patient-Derived Xenograft Model for Venous Malformation
    06:51

    A Patient-Derived Xenograft Model for Venous Malformation

    Published on: June 15, 2020

    5.9K
    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
    07:57

    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

    Published on: August 25, 2022

    3.6K

    Related Experiment Videos

    Last Updated: Apr 13, 2026

    Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
    05:30

    Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach

    Published on: August 8, 2025

    758
    A Patient-Derived Xenograft Model for Venous Malformation
    06:51

    A Patient-Derived Xenograft Model for Venous Malformation

    Published on: June 15, 2020

    5.9K
    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin
    07:57

    Modeling Neonatal Intraventricular Hemorrhage Through Intraventricular Injection of Hemoglobin

    Published on: August 25, 2022

    3.6K